Mounjaro Day 2: What Most People Notice After Their First Injection

Nausea on day 2 is common and typically at its most noticeable in the first 24–48 hours after the starter dose.
The 2.5mg starting dose is designed to help your body adjust gradually — side effects at this stage tend to be milder than at higher doses.
Reduced appetite and slower gastric emptying can begin within hours of the first injection, though the degree varies between individuals.
Symptoms that are severe, persistent beyond a few days, or accompanied by intense abdominal pain need prompt medical assessment.

Day 2 on Mounjaro is usually when you start to notice the first physical signs that something has changed. For most people this means some degree of nausea, reduced appetite, or a general feeling of fullness arriving sooner than usual — sometimes all three at once. These early sensations are a normal part of how tirzepatide settles into your system, and they nearly always ease within days. Mounjaro is a prescription-only medicine; a clinician reviews your suitability before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What actually happens in your body on day 2, and when to be concerned

The morning after: what day 2 on Mounjaro typically feels like

Picture this: you did your first injection yesterday evening, put the pen back in the fridge, and got on with your night. Now it's day 2 and you've woken up feeling slightly off, a low-grade queasiness sitting somewhere behind your sternum, less interest in breakfast than usual, maybe a faint tiredness you can't quite place. For a large number of people starting Mounjaro, that description fits almost exactly.

Tirzepatide activates two gut-hormone receptors, GIP and GLP-1, that slow the rate at which food leaves your stomach and signal to the brain that you are full. Those signals don't wait until you've eaten; they begin reshaping your appetite from the first dose. By day 2 the medicine is still rising toward its peak concentration in your blood, so what you feel now is likely milder than what you might experience after a dose increase later in your schedule.

Fatigue and mild headache are also reported by some people in the first couple of days, and if you want to understand what to expect before symptoms even begin, our guide to Mounjaro day 1 walks through the hours immediately after your first injection. The full Mounjaro overview has more on how the medicine works across the treatment course.

The side effects most likely to show up on day 2, and how long they tend to last

A question our prescribers hear most weeks is: "Is it normal to feel this rough after just one injection?" The honest answer is that some people feel very little on day 2, while others find the nausea genuinely disruptive. Both are within the normal range at the 2.5mg starter dose.

The most common early side effects, as documented by the NHS tirzepatide medicines page and the clinical trial data behind Mounjaro's UK licence, are nausea, constipation, diarrhoea, indigestion, burping and injection-site redness or discomfort. Nausea tends to peak in the day or two after each injection, then gradually settles. For most people starting at 2.5mg it eases within three to five days. It often returns, temporarily, after each dose increase.

Eating smaller portions, choosing lower-fat foods, and avoiding lying down immediately after eating can all help reduce the intensity. If you're finding plain crackers and ginger tea are carrying you through day 2, you're not alone. What typically gets better: nausea, fatigue and headache. What occasionally needs watching: any vomiting that makes it hard to keep fluids down, or diarrhoea that persists beyond a day or two.

You can read about what to expect on day 3 as the first week unfolds.

When day 2 symptoms cross the line: what needs urgent attention

Most day-2 discomfort is unpleasant rather than dangerous. However, some symptoms warrant prompt medical attention rather than waiting it out. Severe, persistent abdominal pain (particularly pain that radiates toward your back, with or without vomiting) should not be ignored. This symptom pattern can indicate acute pancreatitis, a known but infrequent risk with GLP-1 medicines. In January 2026, the MHRA issued a Drug Safety Update specifically reminding patients and healthcare professionals to seek urgent help for this presentation.

Other signs that go beyond typical first-dose adjustment: signs of severe dehydration (dizziness, very little urine, rapid heartbeat), a significant allergic reaction (swelling of the face or throat, difficulty breathing), or pain at the injection site that is spreading or worsening rather than settling. None of these are common, but they're worth knowing before you start any course of treatment.

If you have concerns about your day-2 experience and aren't sure whether they're normal, contacting your prescribing team directly is always the right move. You can also reach the nume support team, who are available seven days a week.

Day 2 in the bigger picture of your first week

Day 2 is arguably the most uncertain point of the whole treatment course, simply because everything is unfamiliar. You don't yet know how your body responds to tirzepatide, you haven't established a routine around injection day, and the side effects (however mild) are new. That uncertainty is worth naming.

What tends to become clearer over the following days is your individual pattern. Some people find day 2 is the worst of it, and by day 5 they feel close to normal. Others find the queasiness lingers a little longer but is manageable. The day-by-day Mounjaro guide maps out what the first week typically looks like across both camps.

It's worth remembering what day 2 is not: it's not the point at which the medicine is supposed to be producing weight loss. The 2.5mg starting dose exists specifically to give your body time to adjust; the clinical work happens as the dose is titrated upward over subsequent months under your prescriber's oversight. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average weight reductions of around 20–21% at the 15mg maintenance dose over 72 weeks, a timeline measured in months, not days.

For context on how private treatment is structured and what the process costs, the Mounjaro pricing page breaks it down clearly. And if you're further along your first week, day 5 is often when the appetite-suppression effect starts to feel more settled and consistent.

If you'd like a clinician to review whether Mounjaro is right for you, speak to our prescribers through a free consultation, no waiting list, reviewed the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions